EA201201530A1 - Комбинация 4-{3-[цис-гексагидроциклопента[c]пиррол-2-(1h)-ил]пропокси} бензамида и антагониста nmda-рецептора и фармацевтические композиции, которые её содержат - Google Patents
Комбинация 4-{3-[цис-гексагидроциклопента[c]пиррол-2-(1h)-ил]пропокси} бензамида и антагониста nmda-рецептора и фармацевтические композиции, которые её содержатInfo
- Publication number
- EA201201530A1 EA201201530A1 EA201201530A EA201201530A EA201201530A1 EA 201201530 A1 EA201201530 A1 EA 201201530A1 EA 201201530 A EA201201530 A EA 201201530A EA 201201530 A EA201201530 A EA 201201530A EA 201201530 A1 EA201201530 A1 EA 201201530A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- antagonist
- benzamide
- propoxy
- combination
- hydrogector
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Комбинация 4-{3-[цис-гексагидроциклопента[с]пиррол-2(1H)-ил]пропокси}бензамида формулы (I)или его соли присоединения фармацевтически приемлемой кислоты или основания и антагониста глутаматного NMDA-рецептора. Лекарственные средства.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161568831P | 2011-12-09 | 2011-12-09 | |
FR1103777A FR2983732B1 (fr) | 2011-12-09 | 2011-12-09 | Nouvelle association entre le 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}pharmaceutiques qui la contiennent |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201201530A1 true EA201201530A1 (ru) | 2013-07-30 |
Family
ID=47682151
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201201530A EA201201530A1 (ru) | 2011-12-09 | 2012-12-07 | Комбинация 4-{3-[цис-гексагидроциклопента[c]пиррол-2-(1h)-ил]пропокси} бензамида и антагониста nmda-рецептора и фармацевтические композиции, которые её содержат |
Country Status (27)
Country | Link |
---|---|
US (2) | US8921409B2 (ru) |
EP (1) | EP2601942A1 (ru) |
JP (1) | JP5591310B2 (ru) |
KR (1) | KR101489670B1 (ru) |
CN (1) | CN103157111B (ru) |
AP (1) | AP3225A (ru) |
AR (1) | AR089112A1 (ru) |
AU (1) | AU2012258339A1 (ru) |
BR (1) | BR102012031031A2 (ru) |
CA (1) | CA2798549A1 (ru) |
CL (1) | CL2012003437A1 (ru) |
CO (2) | CO6660080A1 (ru) |
CR (1) | CR20120608A (ru) |
EA (1) | EA201201530A1 (ru) |
EC (1) | ECSP12012329A (ru) |
FR (1) | FR2983732B1 (ru) |
GT (1) | GT201200329A (ru) |
MA (1) | MA34867B1 (ru) |
MD (1) | MD4348B1 (ru) |
MX (1) | MX2012014184A (ru) |
NI (1) | NI201200178A (ru) |
PE (1) | PE20130813A1 (ru) |
SG (1) | SG191494A1 (ru) |
TN (1) | TN2012000563A1 (ru) |
TW (1) | TWI457123B (ru) |
UY (1) | UY34475A (ru) |
WO (1) | WO2013083887A1 (ru) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3003466B1 (fr) * | 2013-03-22 | 2015-08-07 | Servier Lab | Utilisation du 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide pour le traitement des douleurs neuropathiques |
KR101484405B1 (ko) * | 2013-08-14 | 2015-01-19 | 서울대학교산학협력단 | Ninjurin1 결핍 유래의 강박증 예방 또는 치료용 약학적 조성물 |
GB201509134D0 (en) * | 2015-05-28 | 2015-07-15 | Electrophoretics Ltd | Biomolecules involved in Alzheimer's disease |
US11617734B2 (en) * | 2015-07-22 | 2023-04-04 | Anavex Life Sciences Corp. | Enantiomers of A2-73, analogues, and sigma agonist activity |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60324788D1 (de) * | 2002-05-31 | 2009-01-02 | Lundbeck & Co As H | Kombination aus einem nmda-antagonist und acetylcholinesterase-hemmern zur behandlung der alzheimer-krankheit |
EP1631274A4 (en) * | 2003-05-27 | 2007-03-28 | Forest Laboratories | COMBINATION OF A NMDA RECEPTOR ANTAGONIST AND A SELECTIVE SEROTONINE RECOURSE HEMMER FOR TREATING DEPRESSIONS AND OTHER MUTUAL DISORDERS |
US7432280B2 (en) * | 2003-06-20 | 2008-10-07 | Eli Lilly And Company | 3-aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake |
WO2005067908A2 (en) * | 2004-01-05 | 2005-07-28 | Merz Pharma Gmbh & Co. Kgaa | Memantine for the treatment of mild and mild-to-moderate alzheimer’s disease |
FR2866647B1 (fr) * | 2004-02-20 | 2006-10-27 | Servier Lab | Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
TW200531680A (en) * | 2004-03-03 | 2005-10-01 | Merz Pharma Gmbh & Co Kgaa | Therapy using 1-aminocyclohexane derivatives for the treatment of behavioral disorders associated with alzheimer's disease |
WO2005092009A2 (en) * | 2004-03-19 | 2005-10-06 | Axonyx, Inc. | Acetylcholinesterase inhibitors and n-methyl-d-aspartate antagonists useful in the treatment of cognitive disorders |
FR2937119B1 (fr) | 2008-10-15 | 2010-12-17 | Air Liquide | Procede de production d'energie et capture de co2 |
FR2937251B1 (fr) * | 2008-10-16 | 2011-03-18 | Servier Lab | Utilisation du 4-{3-°hexahydrocyclopenta°c!pyrrol-2(1h)-yl! propoxy}benzamide pour l'obtention de medicaments destines au traitement des troubles du sommeil |
FR2953515B1 (fr) * | 2009-12-09 | 2011-12-23 | Servier Lab | Nouveaux derives du type hexahydrocyclopenta[b]pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
2011
- 2011-12-09 FR FR1103777A patent/FR2983732B1/fr not_active Expired - Fee Related
-
2012
- 2012-04-27 CO CO12069442A patent/CO6660080A1/es unknown
- 2012-11-28 UY UY0001034475A patent/UY34475A/es unknown
- 2012-11-28 PE PE2012002234A patent/PE20130813A1/es not_active Application Discontinuation
- 2012-11-28 AU AU2012258339A patent/AU2012258339A1/en not_active Abandoned
- 2012-11-29 TN TNP2012000563A patent/TN2012000563A1/fr unknown
- 2012-11-29 SG SG2012087771A patent/SG191494A1/en unknown
- 2012-12-03 CR CR20120608A patent/CR20120608A/es unknown
- 2012-12-03 MD MDA20120119A patent/MD4348B1/ru not_active IP Right Cessation
- 2012-12-03 NI NI201200178A patent/NI201200178A/es unknown
- 2012-12-03 MA MA35425A patent/MA34867B1/fr unknown
- 2012-12-05 MX MX2012014184A patent/MX2012014184A/es not_active Application Discontinuation
- 2012-12-05 BR BR102012031031-7A patent/BR102012031031A2/pt not_active Application Discontinuation
- 2012-12-05 AP AP2012006607A patent/AP3225A/xx active
- 2012-12-06 TW TW101145875A patent/TWI457123B/zh not_active IP Right Cessation
- 2012-12-06 CA CA2798549A patent/CA2798549A1/fr not_active Abandoned
- 2012-12-06 US US13/706,828 patent/US8921409B2/en not_active Expired - Fee Related
- 2012-12-06 CL CL2012003437A patent/CL2012003437A1/es unknown
- 2012-12-06 CO CO12221472A patent/CO6690116A1/es unknown
- 2012-12-06 KR KR20120141338A patent/KR101489670B1/ko not_active IP Right Cessation
- 2012-12-06 JP JP2012267342A patent/JP5591310B2/ja not_active Expired - Fee Related
- 2012-12-07 WO PCT/FR2012/000505 patent/WO2013083887A1/fr active Application Filing
- 2012-12-07 EP EP12195997.7A patent/EP2601942A1/fr not_active Withdrawn
- 2012-12-07 EA EA201201530A patent/EA201201530A1/ru unknown
- 2012-12-07 EC ECSP12012329 patent/ECSP12012329A/es unknown
- 2012-12-07 AR ARP120104595A patent/AR089112A1/es unknown
- 2012-12-07 GT GT201200329A patent/GT201200329A/es unknown
- 2012-12-10 CN CN201210530112.9A patent/CN103157111B/zh not_active Expired - Fee Related
-
2014
- 2014-11-25 US US14/553,206 patent/US20150080448A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1123365T1 (el) | Ενωσεις που εχουν δραστικοτητα ανταγωνιστη μουσκαρινικου υποδοχεα και αγωνιστη βητα2 αδρενεργικου υποδοχεα | |
CY1118379T1 (el) | Αναστολεις ιου ηπατιτιδας c | |
PH12015500064B1 (en) | Imidazotriazinecarbonitriles useful as kinase inhibitors | |
CY1118839T1 (el) | Επικαλυμμενη φαρμακευτικη συνθεση που περιεχει ρεγοραφενιμπη | |
PH12015501339A1 (en) | Indole carboxamide derivatives as p2x7 receptor antagonists | |
EA201401351A1 (ru) | Производные бензимидазол-пролина | |
EA201690848A1 (ru) | Производные бициклического пиридила с конденсированными кольцами в качестве ингибиторов fgfr4 | |
EA201590930A1 (ru) | Лекарственные формы руксолитиниба с замедленным высвобождением | |
EA201370166A1 (ru) | Содержащие диарилацетиленгидразид ингибиторы тирозинкиназы | |
PH12014502586A1 (en) | Novel ring-substituted n-pyridinyl amides as kinase inhibitors | |
EA201390977A1 (ru) | Комбинация агониста опиоидных рецепторов и антагониста опиоидных рецепторов для лечения болезни паркинсона | |
GEP201606526B (en) | 5-ht3 receptor antagonists | |
EA201490471A1 (ru) | Пиридазиноновые соединения и их применение в качестве ингибиторов daao | |
EA201500298A1 (ru) | Алкоксипиразолы в качестве активаторов растворимой гуанилатциклазы | |
EA201200527A1 (ru) | НОВАЯ АССОЦИАЦИЯ МЕЖДУ 4-{3-[ЦИС-ГЕКСАГИДРОЦИКЛОПЕНТА[c]ПИРРОЛ-2(1H)-ИЛ]ПРОПОКСИ}БЕНЗАМИДОМ И ИНГИБИТОРОМ АЦЕТИЛХОЛИНЭСТЕРАЗЫ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, КОТОРЫЕ ЕЕ СОДЕРЖАТ | |
EA201370149A1 (ru) | Антагонисты рецептора | |
EA201300034A1 (ru) | Фармацевтические композиции, содержащие иматиниб или его фармацевтически приемлемую соль, и способы их получения | |
EA201400822A1 (ru) | Производные гетероциклических амидов в качестве антагонистов p2xрецептора | |
EA201692298A1 (ru) | Производные карбоксамидов | |
PH12016500322A1 (en) | Amide derivatives as lysophosphatidic acid receptor antagonists | |
EA201201530A1 (ru) | Комбинация 4-{3-[цис-гексагидроциклопента[c]пиррол-2-(1h)-ил]пропокси} бензамида и антагониста nmda-рецептора и фармацевтические композиции, которые её содержат | |
EA201300857A1 (ru) | Пиразолы в качестве антагонистов crth2 | |
EA201200726A1 (ru) | Способ синтеза, кристаллическая форма 4-{3-[цис-гексагидроциклопента[c]пиррол-2(1н)ил]пропокси}бензамид гидрохлорида и фармацевтические композиции, которые ее содержат | |
EA201100230A1 (ru) | Новый способ синтеза ивабрадина и его аддитивных солей с фармацевтически приемлемой кислотой | |
EA201301136A2 (ru) | Новый способ синтеза (2e)-3-(3,4-диметоксифенил)проп-2-еннитрила, применение в синтезе ивабрадина и его фармацевтически приемлемых кислотно-аддитивных солей |